
Insun Kang
Examiner (ID: 13166, Phone: (571)272-3724 , Office: P/2193 )
| Most Active Art Unit | 2193 |
| Art Unit(s) | 2198, 2193, 2124 |
| Total Applications | 943 |
| Issued Applications | 727 |
| Pending Applications | 50 |
| Abandoned Applications | 188 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17141990
[patent_doc_number] => 20210310002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => CATIONIC COMPOUNDS FOR DELIVERY OF NUCLEIC ACIDS
[patent_app_type] => utility
[patent_app_number] => 17/270832
[patent_app_country] => US
[patent_app_date] => 2019-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30965
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17270832
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/270832 | CATIONIC COMPOUNDS FOR DELIVERY OF NUCLEIC ACIDS | Aug 29, 2019 | Pending |
Array
(
[id] => 17482577
[patent_doc_number] => 20220090081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => NOVEL DNA APTAMER AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/416858
[patent_app_country] => US
[patent_app_date] => 2019-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7543
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17416858
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/416858 | DNA aptamers for pancreatic cancer detection | Aug 7, 2019 | Issued |
Array
(
[id] => 17141996
[patent_doc_number] => 20210310008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => PARN AS A BIOMARKER AND THERAPEUTIC TARGET
[patent_app_type] => utility
[patent_app_number] => 17/266502
[patent_app_country] => US
[patent_app_date] => 2019-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20492
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17266502
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/266502 | PARN AS A BIOMARKER AND THERAPEUTIC TARGET | Aug 6, 2019 | Pending |
Array
(
[id] => 17837732
[patent_doc_number] => 20220275037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => ss-AMYLOID CYCLIC RIBONUCLEIC ACID, POLYPEPTIDE, AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/627991
[patent_app_country] => US
[patent_app_date] => 2019-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14089
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17627991
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/627991 | ss-AMYLOID CYCLIC RIBONUCLEIC ACID, POLYPEPTIDE, AND APPLICATION THEREOF | Jul 18, 2019 | Pending |
Array
(
[id] => 17112178
[patent_doc_number] => 20210292775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => System and Methods for Engineering Bacteria Fit for Eukaryotic mRNA Production, Export, and Translation in a Eukaryotic Host
[patent_app_type] => utility
[patent_app_number] => 17/257837
[patent_app_country] => US
[patent_app_date] => 2019-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27192
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17257837
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/257837 | System and Methods for Engineering Bacteria Fit for Eukaryotic mRNA Production, Export, and Translation in a Eukaryotic Host | Jul 4, 2019 | Pending |
Array
(
[id] => 17830462
[patent_doc_number] => 20220267766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => RNA INTERFERENCE-INDUCING NUCLEIC ACID INHIBITING NONCANONICAL TARGETS OF MICRO RNA, AND USE FOR SAME
[patent_app_type] => utility
[patent_app_number] => 17/059736
[patent_app_country] => US
[patent_app_date] => 2019-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43073
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17059736
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/059736 | RNA INTERFERENCE-INDUCING NUCLEIC ACID INHIBITING NONCANONICAL TARGETS OF MICRO RNA, AND USE FOR SAME | May 30, 2019 | Pending |
Array
(
[id] => 16977959
[patent_doc_number] => 20210222196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => MODIFIED AAV CONSTRUCTS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/054794
[patent_app_country] => US
[patent_app_date] => 2019-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12120
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17054794
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/054794 | Modified AAV constructs and uses thereof | May 14, 2019 | Issued |
Array
(
[id] => 17426820
[patent_doc_number] => 20220054528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => TREATMENT OF ADULT T CELL LEUKEMIA/LYMPHOMA (ATLL) USING MIR-155 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/299415
[patent_app_country] => US
[patent_app_date] => 2019-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26663
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17299415
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/299415 | TREATMENT OF ADULT T CELL LEUKEMIA/LYMPHOMA (ATLL) USING MIR-155 INHIBITORS | May 14, 2019 | Abandoned |
Array
(
[id] => 16628993
[patent_doc_number] => 20210047646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => Compositions Comprising Immune System Activators and Method of Using Same
[patent_app_type] => utility
[patent_app_number] => 17/044195
[patent_app_country] => US
[patent_app_date] => 2019-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6687
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17044195
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/044195 | Compositions Comprising Immune System Activators and Method of Using Same | Apr 8, 2019 | Pending |
Array
(
[id] => 16581482
[patent_doc_number] => 20210015884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => MODIFIED OLIGONUCLEOTIDES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/040029
[patent_app_country] => US
[patent_app_date] => 2019-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11337
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17040029
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/040029 | MODIFIED OLIGONUCLEOTIDES AND METHODS OF USE | Mar 20, 2019 | Abandoned |
Array
(
[id] => 17480553
[patent_doc_number] => 20220088057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => THERAPEUTIC AGENT FOR FIBROSIS
[patent_app_type] => utility
[patent_app_number] => 17/424004
[patent_app_country] => US
[patent_app_date] => 2019-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12579
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17424004
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/424004 | THERAPEUTIC AGENT FOR FIBROSIS | Jan 24, 2019 | Abandoned |